Forum on Drug Discovery, Development, and Translation

项目摘要 全国药物发现、开发与翻译论坛(论坛) 科学院、工程院和医学院(国家科学院)成立于2005年 由国家科学院健康科学政策委员会促进交流， 在药物研究中共同关心的问题上，在中立的环境下进行合作和采取行动 和开发生命周期。论坛成员包括来自国家研究院的领导人 卫生部、美国食品和药物管理局、生物制药行业、学术界、 财团、基金会、期刊、以患者为中心的组织和疾病倡导组织。穿过 在论坛的活动中，与会者能够更好地引起对 重要问题，探索解决问题领域的新方法，共享信息和查找 共同点，共同努力，将想法转化为具体行动和新的合作。 论坛每年召开几次会议，以确定和讨论#年的关键问题和战略。 药物的发现、开发和转化。补充观点和专业知识 在其成员中，论坛还举办公开讲习班，邀请广泛的专家参加， 公众和政策界。论坛还促进了以下方面的合作 它的成员和选民。 论坛是培育新想法和伙伴关系的枢纽和催化剂，并提供 为利益相关者提供中立的空间，推动生物制药的关键政策讨论 国内和全球的创新。展望未来，论坛计划重点关注重要问题 这种对高度流行的慢性疾病药物研发的改进创新 疾病，并加速朝着更有效率的临床试验企业发展， 有效，以患者为中心，并融入医疗服务体系。 有关药物发现、开发和翻译论坛的更多信息，请 访问网址：www.National Academy Semes.org/Drug

Project Summary The Forum on Drug Discovery, Development, and Translation (the Forum) of the National Academies of Sciences, Engineering, and Medicine (the National Academies) was created in 2005 by the National Academies’ Board on Health Sciences Policy to foster communication, collaboration, and action in a neutral setting on issues of mutual interest across the drug research and development lifecycle. The Forum membership includes leaders from the National Institutes of Health, the U.S. Food and Drug Administration, the biopharmaceutical industry, academia, consortia, foundations, journals, and patient-focused and disease advocacy organizations. Through the Forum’s activities, participants have been better able to bring attention and visibility to important issues, explore new approaches for resolving problem areas, share information and find common ground, and work together to develop ideas into concrete actions and new collaborations. The Forum convenes a few times each year to identify and discuss key problems and strategies in the discovery, development, and translation of drugs. To supplement the perspectives and expertise of its members, the Forum also holds public workshops to engage a wide range of experts, members of the public, and the policy community. The Forum also fosters collaborations among its members and constituencies. The Forum serves as a hub and catalyst for nurturing new ideas and partnerships and offers a neutral space for stakeholders to advance critical policy discussions on biopharmaceutical innovation nationally and globally. Looking ahead, the Forum plans to focus on important issues such improving innovation in drug research and development for highly prevalent chronic diseases, and accelerating progress towards a clinical trials enterprise that is more efficient, effective, patient-centered, and integrated into the health delivery system. For more information about the Forum on Drug Discovery, Development, and Translation, please visit www.nationalacademies.org/Drug